343 related articles for article (PubMed ID: 23861322)
61. Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization.
Dinevska M; Widodo SS; Furst L; Cuzcano L; Fang Y; Mangiola S; Neeson PJ; Darcy PK; Ramsay RG; Hutchinson R; MacKay F; Christie M; Stylli SS; Mantamadiotis T
Cell Oncol (Dordr); 2023 Jun; 46(3):589-602. PubMed ID: 36567397
[TBL] [Abstract][Full Text] [Related]
62. The Role of BEHAB/Brevican in the Tumor Microenvironment: Mediating Glioma Cell Invasion and Motility.
Giamanco KA; Matthews RT
Adv Exp Med Biol; 2020; 1272():117-132. PubMed ID: 32845505
[TBL] [Abstract][Full Text] [Related]
63. The ability in adhesion and invasion of drug-resistant human glioma cells.
Hikawa T; Mori T; Abe T; Hori S
J Exp Clin Cancer Res; 2000 Sep; 19(3):357-62. PubMed ID: 11144529
[TBL] [Abstract][Full Text] [Related]
64. Injectable three-dimensional tumor microenvironments to study mechanobiology in ovarian cancer.
Horst EN; Novak CM; Burkhard K; Snyder CS; Verma R; Crochran DE; Geza IA; Fermanich W; Mehta P; Schlautman DC; Tran LA; Brezenger ME; Mehta G
Acta Biomater; 2022 Jul; 146():222-234. PubMed ID: 35487424
[TBL] [Abstract][Full Text] [Related]
65. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.
Wick W; Platten M; Weller M
J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069
[TBL] [Abstract][Full Text] [Related]
66. The emergent role of exosomes in glioma.
Gourlay J; Morokoff AP; Luwor RB; Zhu HJ; Kaye AH; Stylli SS
J Clin Neurosci; 2017 Jan; 35():13-23. PubMed ID: 27771233
[TBL] [Abstract][Full Text] [Related]
67. Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake.
Zinnhardt B; Pigeon H; Thézé B; Viel T; Wachsmuth L; Fricke IB; Schelhaas S; Honold L; Schwegmann K; Wagner S; Faust A; Faber C; Kuhlmann MT; Hermann S; Schäfers M; Winkeler A; Jacobs AH
Cancer Res; 2017 Apr; 77(8):1831-1841. PubMed ID: 28137769
[TBL] [Abstract][Full Text] [Related]
68. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
69. Galectins and gliomas.
Le Mercier M; Fortin S; Mathieu V; Kiss R; Lefranc F
Brain Pathol; 2010 Jan; 20(1):17-27. PubMed ID: 19371355
[TBL] [Abstract][Full Text] [Related]
70. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
71. Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes.
Chen W; Wang D; Du X; He Y; Chen S; Shao Q; Ma C; Huang B; Chen A; Zhao P; Qu X; Li X
Med Oncol; 2015 Mar; 32(3):43. PubMed ID: 25631631
[TBL] [Abstract][Full Text] [Related]
72. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
73. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.
Savaskan NE; Seufert S; Hauke J; Tränkle C; Eyüpoglu IY; Hahnen E
Oncogene; 2011 Jan; 30(1):43-53. PubMed ID: 20802520
[TBL] [Abstract][Full Text] [Related]
74. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
75. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators.
Kadler KE; Hill A; Canty-Laird EG
Curr Opin Cell Biol; 2008 Oct; 20(5):495-501. PubMed ID: 18640274
[TBL] [Abstract][Full Text] [Related]
76. Immune Modulatory Properties of Collagen in Cancer.
Rømer AMA; Thorseth ML; Madsen DH
Front Immunol; 2021; 12():791453. PubMed ID: 34956223
[TBL] [Abstract][Full Text] [Related]
77. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
78. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
[TBL] [Abstract][Full Text] [Related]
79. The collagen family members as cell adhesion proteins.
Heino J
Bioessays; 2007 Oct; 29(10):1001-10. PubMed ID: 17876790
[TBL] [Abstract][Full Text] [Related]
80. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Liu J; Li G
Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
